![Linda P. Dwoskin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Linda P. Dwoskin
Sociétés | Poste | Début | Fin |
---|---|---|---|
Ceptaris Therapeutics, Inc.
![]() Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Fondateur | 18/03/2010 | - |
Corporate Officer/Principal | 18/03/2010 | - |
Historique de carrière de Linda P. Dwoskin
Statistiques
Internationale
Etats-Unis | 2 |
Opérationnelle
Founder | 1 |
Corporate Officer/Principal | 1 |
Sectorielle
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Ceptaris Therapeutics, Inc.
![]() Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ceptaris Therapeutics, Inc. develops mechlorethamine gels. The firm develops a gel formulation of mechlorethamine hydrochloride for the treatment of early stage (stages I-IIA) mycosis fungoides, a type of Cutaneous T-Cell Lymphoma. The company was founded in 2002 and is headquartered in Malvern, PA. | Health Technology |
- Bourse
- Insiders
- Linda P. Dwoskin
- Expérience